Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. The metric has seen a significant gain of 21.19% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -12.27%. Over the past 30 days, the price of LEGN has leaped by -9.08%. And in the last five days, it has fallen by -6.40%.
The current stock price for Legend Biotech Corp ADR (LEGN) is $60.50. The stock experienced a significant increase during the last trading session, reaching $64.30 after opening at $64.04. It dipped to a low of $60.26 before ultimately closing at $64.56.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
The stock market performance of Legend Biotech Corp ADR has been very steady. Over the last year, the company’s stock hit its highest at $77.32 on 07/21/23, while the lowest price during the same time frame was $42.90, recorded on 03/10/23.
52-week price history of LEGN Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Legend Biotech Corp ADR’s current trading price is -21.75% away from its 52-week high, while its distance from the 52-week low is 41.01%. The stock’s price range over this timeframe has been between $42.90 and $77.32. The shares of the Healthcare sector company recorded a trading volume of approximately 1.69 million for the day, which was comparatively higher than the average daily volume of 0.5 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Legend Biotech Corp ADR (LEGN) has experienced a quarterly decline of -13.09% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 9.99B and boasts a workforce of 1387 employees.
Expert Opinions: Analysts’ Ratings for Legend Biotech Corp ADR
As of right now, 12 analysts are rating Legend Biotech Corp ADR as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 68.03, with a change in price of -9.70. Similarly, Legend Biotech Corp ADR recorded 560,238 in trading volume during the last 100 days, posting a change of -13.82%.
LEGN’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for LEGN stands at 0.23. Similarly, the long-term debt-to-equity ratio is also 0.22.
LEGN Stock Stochastic Average
The raw stochastic average for Legend Biotech Corp ADR over the last 50 days is presently at 2.28%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 3.03%. Further, the company’s Stochastic %K and %D values for the last 20 days were 19.25% and 27.37%, respectively.
